SYNCHRONOSS TECHNOLOGIES INC Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020
Operating activities:
Net income (loss) from continuing operations
Gain (loss) on Sale of discontinued operations, net of tax
Net loss from discontinued operations
Adjustments to reconcile net income (loss) to net cash from operating activities:
Goodwill impairment
Change in fair value of financial instruments
Depreciation and amortization
Impairment of long-lived assets and capitalized software
Amortization of debt issuance costs
Gain on extinguishment of debt
Accrued PIK interest
Allowance for loan losses
Loss from Equity method investments
Loss on disposals of fixed assets
Gain on sale of DXP
Loss on divestiture
Gain on disposals of intangible assets
Amortization of debt discount
Sublease receivable impairment
Deferred income taxes
Stock-based compensation
Cumulative adjustment to STI receivable
Contingent consideration obligation
Impairment of STI Loan and iQmetrix receivable
Operating lease impairment, net
Other, net
Changes in operating assets and liabilities:
Accounts receivable, net
Prepaid expenses and other current assets
Accounts payable
Accrued expenses
Other assets
Deferred revenues
Other liabilities

Net cash provided by operating activities

Investing activities:
Purchases of fixed assets
Additions to capitalized software
Acquisition of intangible assets
Proceeds from the sale of intangibles
Purchases of marketable securities available for sale
Proceeds from the divestiture, net
Maturity of marketable securities available for sale
Equity investment
Business acquired, net of cash
Proceeds from the sale of DXP
Net cash (used in) provided by investing activities

Financing activities:
Share-based compensation-related proceeds, net of taxes paid on withholding shares
Taxes paid on withholding shares
Debt issuance costs related to long-term debt
Proceeds from issuance of long term debt
Borrowings on revolving line of credit
Proceeds from issuance of Term Loan
Retirement of Senior Notes and related costs
Repayment of Term Loan
Drawdown on A/R Facility
Proceeds from issuance of common stock
Stock issuance costs
Common Stock
Preferred Stock
Series B Preferred Stock

Proceeds from issuance of Series B Preferred stock
Repayment of A/R Facility
Series B Preferred dividend paid in the form of cash
Series B Preferred Stock
Series A Preferred Stock
Total series B Preferred dividend paid in the form of cash

Redemption of Series B Preferred stock
Series B Preferred Stock
Series A Preferred Stock
Total redemption of Series B Preferred stock

Payments on capital obligations
Net cash used in financing activities
Effect of exchange rate changes on cash
Net increase (decrease) in cash and cash equivalents
Beginning cash and cash equivalents of continuing operations
Beginning cash and cash equivalents of discontinued operations
Beginning cash and cash equivalents
Ending cash and cash equivalents of continuing operations
Ending cash and cash equivalents of discontinued operations
Ending cash and cash equivalents
Supplemental disclosures of cash flow information:
Cash paid for income taxes
Cash refund for income taxes
Cash paid for interest
Supplemental disclosures of non-cash investing and financing activities:
Gain on Series B Preferred stock redemption
Gain on Senior Notes repurchase
Amortization of Series B Preferred stock issuance costs and paid in kind dividends
Series B Preferred Stock
Series A Preferred Stock
Total amortization of Series B Preferred stock issuance costs and paid in kind dividends

Comments